NANOG and pancreatic adenocarcinoma: In pancreatic adenocarcinoma, the lncRNA ROR was shown to act as a ceRNA, and decreased ROR expression could inhibit cell proliferation, invasion and tumorigenicity by modulating Nanog and sponging miR‐145 18.